BDSX Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $26.86M ; Research and development $3.13M ; Selling, general and administrative $24.28M ; Operating expenses $32.25M . 2026-03-31: Revenue $25.55M ; Research and development $3.29M ; Selling, general and administrative $24.26M ; Operating expenses $31.76M . 2025-12-31: Revenue $28.75M* ; Research and development $2.87M* ; Selling, general and administrative $22.97M* ; Operating expenses $30.72M* . 2025-09-30: Revenue $21.77M ; Research and development $2.99M ; Selling, general and administrative $21.71M ; Operating expenses $28.82M . Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
BDSX revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Development Services $1.51M Diagnostic Tests $25.35M Revenue $26.86M Operating expenses $32.25M Operating income -$5.39M Other income, net $97.00K Research & development $3.14M Selling, general & administrative $24.28M Net income -$7.27M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2026-06-30 $26.86M $3.13M $24.28M $32.25M (m) -$7.27M 2026-03-31 $25.55M $3.29M $24.26M $31.76M $0.00 -$7.79M 2025-12-31 $28.75M* $2.87M* $22.97M* $30.72M* $0.00* -$3.98M* 2025-09-30 $21.77M $2.99M $21.71M $28.82M (m) -$8.72M 2025-06-30 $20.02M $3.27M $22.41M $29.74M (m) -$11.47M 2025-03-31 $17.96M $2.87M $20.45M $27.09M $0.00 -$11.10M 2024-12-31 (m) (m) (m) (m) $0.00* (m) 2024-09-30 $18.15M $2.55M $20.02M $26.74M (m) -$10.26M 2024-06-30 $17.93M $2.56M $19.66M $26.16M (m) -$10.81M 2024-03-31 $14.82M $2.04M $20.56M $25.84M $0.00 -$13.61M 2023-12-31 (m) (m) (m) (m) $0.00* (m) 2023-09-30 $13.49M $1.94M $15.50M $20.66M (m) -$10.95M 2023-06-30 $11.87M $2.91M $16.65M $22.80M (m) -$13.36M 2023-03-31 $9.06M $3.25M $18.99M $25.43M $0.00 -$18.70M 2022-12-31 (m) (m) (m) (m) $0.00* (m) 2022-09-30 $11.11M $2.97M $15.11M $21.72M (m) -$13.70M 2022-06-30 $10.95M $3.36M $15.23M $22.58M (m) -$15.82M 2022-03-31 $6.55M $3.21M $14.49M $21.01M $0.00 -$15.59M 2021-12-31 (m) (m) (m) (m) $0.00* (m) 2021-09-30 $6.53M $3.29M $13.61M $19.62M (m) -$11.51M 2021-06-30 $11.88M $3.32M $11.43M $22.47M (m) -$11.40M 2021-03-31 $28.87M $3.32M $11.93M $34.45M $0.00 -$6.96M 2020-12-31 (m) (m) (m) (m) $0.00* (m) 2020-09-30 $9.19M $2.71M $7.88M $15.43M (m) -$8.85M 2020-06-30 $4.24M $2.11M $6.83M $9.86M (m) -$8.27M 2020-03-31 $5.10M $2.90M $8.08M $13.52M (m) -$9.71M 2019-09-30 $3.94M $2.36M $8.21M $12.97M (m) -$9.60M 2019-06-30 (m) (m) (m) (m) (m) -$6.86M 2019-03-31 (m) (m) (m) (m) (m) -$7.74M
Revenue and expense 6 month Period end Revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2026-06-30 $52.42M $6.42M $48.54M $64.00M $0.00 -$15.07M 2025-06-30 $37.98M $6.14M $42.86M $56.83M $0.00 -$22.57M 2024-06-30 $32.74M $4.60M $40.22M $52.00M $0.00 -$24.42M 2023-06-30 $20.93M $6.16M $35.64M $48.23M $0.00 -$32.06M 2022-06-30 $17.50M $6.57M $29.72M $43.59M $0.00 -$31.41M 2021-06-30 $40.75M $6.64M $23.35M $56.92M $0.00 -$18.36M 2020-06-30 $9.34M $5.01M $14.91M $23.38M (m) -$17.97M
Revenue and expense 9 month Period end Revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2025-09-30 $59.74M $9.13M $64.57M $85.65M $0.00 -$31.29M 2024-09-30 $50.89M $7.14M $60.23M $78.74M $0.00 -$34.68M 2023-09-30 $34.42M $8.10M $51.14M $68.89M $0.00 -$43.01M 2022-09-30 $28.61M $9.54M $44.84M $65.30M $0.00 -$45.11M 2021-09-30 $47.28M $9.94M $36.96M $76.54M $0.00 -$29.88M 2020-09-30 $18.53M $7.71M $22.79M $38.81M $0.00 -$26.82M 2019-09-30 $16.28M $7.97M $24.08M $39.48M (m) -$24.20M
Revenue and expense 12 month Period end Revenue Research and development Selling, general and administrative Operating expenses Income tax Net income 2025-12-31 $88.50M $12.00M $87.55M $116.37M $0.00 -$35.27M 2024-12-31 $71.32M $9.56M $80.45M $105.82M $0.00 -$42.93M 2023-12-31 $49.09M $9.99M $67.39M $90.43M $0.00 -$52.15M 2022-12-31 $38.21M $13.10M $61.46M $88.80M $0.00 -$65.45M 2021-12-31 $54.51M $12.79M $50.52M $95.45M $0.00 -$43.16M 2020-12-31 $45.56M $10.82M $34.86M $68.49M $0.00 -$65.45M 2019-12-31 $24.55M $10.47M $30.64M $51.29M (m) -$30.73M